Detalhe da pesquisa
1.
Establishing severe acute respiratory infection (SARI) surveillance in a sentinel hospital, Ireland, 2021 to 2022.
Euro Surveill
; 28(23)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289427
2.
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
Euro Surveill
; 28(4)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700868
3.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill
; 28(47)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997666
4.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill
; 28(47)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37997665
5.
Age-specific associations between underlying health conditions and hospitalisation, death and in-hospital death among confirmed COVID-19 cases: a multi-country study based on surveillance data, June to December 2020.
Euro Surveill
; 27(35)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052721
6.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Euro Surveill
; 27(21)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35620997
7.
Patient functional outcomes and quality of life after surgery for unruptured brain arteriovenous malformation.
Acta Neurochir (Wien)
; 163(7): 2047-2054, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830340
8.
Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020.
Euro Surveill
; 26(2)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446304
9.
Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021.
Euro Surveill
; 26(29)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296676
10.
Test-retest reliability of touchscreen DriveSafe DriveAware.
Aust Occup Ther J
; 68(2): 106-114, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368324
11.
High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020.
Euro Surveill
; 25(22)2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32524949
12.
Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020.
Euro Surveill
; 25(26)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32643601
13.
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort.
Euro Surveill
; 24(48)2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796152
14.
Quality of life and disability 12 months after surgery vs. conservative management for unruptured brain arteriovenous malformations: Scottish population-based and Australian hospital-based studies.
Acta Neurochir (Wien)
; 160(3): 559-566, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327142
15.
Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017.
Euro Surveill
; 22(14)2017 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424146
16.
Tuberculosis contact investigations associated with air travel in Ireland, September 2011 to November 2014.
Euro Surveill
; 21(40)2016 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27748251
17.
I-MOVE multicentre case-control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
Euro Surveill
; 21(16)2016 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27124420
18.
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
Vaccine
; 42(16): 3547-3554, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704257
19.
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.
Influenza Other Respir Viruses
; 18(2): e13255, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403302
20.
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Influenza Other Respir Viruses
; 18(1): e13243, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38204584